The effectiveness and value of eculizumab and efgartigimod for generalized myasthenia gravis

被引：0
|
作者：
Tice, Jeffrey A. [1 ]
Touchette, Daniel R. [2 ]
Lien, Pei-Wen [2 ]
Agboola, Foluso [3 ]
Nikitin, Dmitriy [3 ]
Pearson, Steven D. [3 ]
机构：
[1] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA
[2] Univ Illinois, Coll Pharm, Chicago, IL USA
[3] ICER, Boston, MA USA
来源：
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY | 2022年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：119 / 124
页数：6
相关论文
共 50 条
  • [41] Clinical Experience With Efgartigimod For Treatment Of Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis
    Katyal, Nakul
    Halldorsdottir, Karen
    Goyal, Neelam
    Govindarajan, Raghav
    Muppidi, Srikanth
    Habib, Ali
    NEUROLOGY, 2023, 100 (17)
  • [42] Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in China
    Luo, Sushan
    Jiang, Qilong
    Zeng, Wenshuang
    Wang, Qinzhou
    Zou, Zhangyu
    Yu, Yanyan
    Hong, Daojun
    Zeng, Quantao
    Tan, Song
    Zhang, Zhouao
    Zhang, Yong
    Guo, Xiuming
    Chen, Jing
    Zhao, Zhongyan
    Huang, Shixiong
    Shi, Jianquan
    Chen, Ying
    Du, Lei
    Yan, Chong
    Xi, Jianying
    Song, Jie
    Zhao, Chongbo
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (08): : 2212 - 2221
  • [43] Efgartigimod demonstrates consistent improvements in patients with generalized myasthenia gravis of shorter disease duration
    Genge, Angela
    Bril, Vera
    Vu, Tuan
    Brauer, Edward
    Kerstens, Rene
    Howard, James F., Jr.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [44] Individualized Dosing of Efgartigimod in Patients With Generalized Myasthenia Gravis: Clinical Experience at a Single Center
    Silvestri, Nicholas J.
    MUSCLE & NERVE, 2025, 71 (03) : 422 - 428
  • [45] LONG-TERM EFFECTIVENESS AND SAFETY OF ECULIZUMAB IN GENERALIZED MYASTHENIA GRAVIS: BEYOND MG-ADL AND QMG
    Muppidi, S.
    O'Brien, F.
    Wang, J.
    Fujita, K.
    Howard, J., Jr.
    MUSCLE & NERVE, 2018, 58 : S115 - S115
  • [46] Efgartigimod in generalized myasthenia gravis: A real-life experience at a national reference center
    Frangiamore, Rita
    Rinaldi, Elena
    Vanoli, Fiammetta
    Andreetta, Francesca
    Ciusani, Emilio
    Bonanno, Silvia
    Maggi, Lorenzo
    Gallone, Annamaria
    Colasuonno, Anna
    Tramacere, Irene
    Cheli, Marta
    Pinna, Alessandro
    Mantegazza, Renato
    Antozzi, Carlo
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (04)
  • [47] Safety and Effectiveness of Eculizumab for Patients with Generalized Myasthenia Gravis in Japan: Interim Analysis of Post-Marketing Surveillance
    Murai, H.
    Suzuki, S.
    Hasebe, M.
    Fukamizu, Y.
    Rodrigues, E.
    Utsugisawa, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 485 - 486
  • [48] Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance
    Murai, Hiroyuki
    Suzuki, Shigeaki
    Hasebe, Miki
    Fukamizu, Yuji
    Rodrigues, Ema
    Utsugisawa, Kimiaki
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [49] EFGARTIGIMOD IN GENERALIZED MYASTHENIA GRAVIS: A MULTICENTER REAL-WORLD COHORT STUDY IN CHINA
    Luo, Sushan
    Jiang, Qilong
    Zeng, Wenshuang
    Wang, Qinzhou
    Zou, Zhangyu
    Yu, Yanyan
    Hong, Daojun
    Zeng, Quantao
    Tan, Song
    Zhang, Zhouao
    Zhang, Yong
    Guo, Xiuming
    Chen, Jing
    Zhao, Zhongyan
    Huang, Shixiong
    Shi, Jianquan
    Chen, Ying
    Du, Lei
    Zhao, Chongbo
    Song, Jie
    Yan, Chong
    Xi, Jianying
    MUSCLE & NERVE, 2024, 70 (03) : 563 - 563
  • [50] REAL-WORLD EXPERIENCE WITH INDIVIDUALIZED DOSING OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
    Silvestri, Nicholas
    MUSCLE & NERVE, 2024, 70 (03) : 638 - 638
12345